Literature DB >> 15727814

Sporadic colorectal cancer--role of the commensal microbiota.

Mairi E Hope1, Georgina L Hold, Renate Kain, Emad M El-Omar.   

Abstract

There are vast numbers of bacteria present within the human colon that are essential for the host's well being in terms of nutrition and mucosal immunity. While certain members of the colonic microbiota have been shown to promote the host's health there are also numerous studies that have implicated other members of the colonic microbiota in the development of colorectal cancer, a prominent malignancy within the western world. In this review we consider the evidence for the role of bacteria in colorectal cancer from molecular and animal model studies. We focus on some of the mechanisms by which the colonic microbiota drives the progression towards colorectal malignancy including generation of reactive metabolites and carcinogens, alterations in host carbohydrate expression and induction of chronic mucosal inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727814     DOI: 10.1016/j.femsle.2005.01.029

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  43 in total

1.  Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88.

Authors:  Sarah E Cheesman; James T Neal; Erika Mittge; Barbara M Seredick; Karen Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells.

Authors:  Gabriel Cuevas-Ramos; Claude R Petit; Ingrid Marcq; Michèle Boury; Eric Oswald; Jean-Philippe Nougayrède
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Authors:  Nina Sanapareddy; Ryan M Legge; Biljana Jovov; Amber McCoy; Lauren Burcal; Felix Araujo-Perez; Thomas A Randall; Joseph Galanko; Andrew Benson; Robert S Sandler; John F Rawls; Zaid Abdo; Anthony A Fodor; Temitope O Keku
Journal:  ISME J       Date:  2012-05-24       Impact factor: 10.302

4.  Perspective: alpha-bugs, their microbial partners, and the link to colon cancer.

Authors:  Cynthia L Sears; Drew M Pardoll
Journal:  J Infect Dis       Date:  2010-12-08       Impact factor: 5.226

5.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

6.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

Review 7.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

8.  Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect.

Authors:  Xingmin Wang; Toby D Allen; Randal J May; Stanley Lightfoot; Courtney W Houchen; Mark M Huycke
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

Authors:  E L Wang; Z R Qian; M Nakasono; T Tanahashi; K Yoshimoto; Y Bando; E Kudo; M Shimada; T Sano
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

Review 10.  Colorectal carcinoma associated with schistosomiasis: a possible causal relationship.

Authors:  Omer E H Salim; Hytham K S Hamid; Salwa O Mekki; Suleiman H Suleiman; Shakir Z Ibrahim
Journal:  World J Surg Oncol       Date:  2010-08-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.